DÃaz Vico, T.; MartÃnez-Amores MartÃnez, B.; Mihic Góngora, L.; Jiménez-Fonseca, P.; Peinado MartÃn, P.; Grao Torrente, I.; GarcÃa Muñoz-Nájar, A.; Durán-Poveda, M.
Systemic Therapeutic Options in Radioiodine-Refractory Differentiated Thyroid Cancer: Current Indications and Optimal Timing. Cancers 2025, 17, 1800.
https://doi.org/10.3390/cancers17111800
AMA Style
DÃaz Vico T, MartÃnez-Amores MartÃnez B, Mihic Góngora L, Jiménez-Fonseca P, Peinado MartÃn P, Grao Torrente I, GarcÃa Muñoz-Nájar A, Durán-Poveda M.
Systemic Therapeutic Options in Radioiodine-Refractory Differentiated Thyroid Cancer: Current Indications and Optimal Timing. Cancers. 2025; 17(11):1800.
https://doi.org/10.3390/cancers17111800
Chicago/Turabian Style
DÃaz Vico, Tamara, Brezo MartÃnez-Amores MartÃnez, Luka Mihic Góngora, Paula Jiménez-Fonseca, Paloma Peinado MartÃn, Irene Grao Torrente, Alejandro GarcÃa Muñoz-Nájar, and Manuel Durán-Poveda.
2025. "Systemic Therapeutic Options in Radioiodine-Refractory Differentiated Thyroid Cancer: Current Indications and Optimal Timing" Cancers 17, no. 11: 1800.
https://doi.org/10.3390/cancers17111800
APA Style
DÃaz Vico, T., MartÃnez-Amores MartÃnez, B., Mihic Góngora, L., Jiménez-Fonseca, P., Peinado MartÃn, P., Grao Torrente, I., GarcÃa Muñoz-Nájar, A., & Durán-Poveda, M.
(2025). Systemic Therapeutic Options in Radioiodine-Refractory Differentiated Thyroid Cancer: Current Indications and Optimal Timing. Cancers, 17(11), 1800.
https://doi.org/10.3390/cancers17111800
